The Role of Nuclear Receptors in the Pathogenesis and Treatment of Non-alcoholic Fatty Liver Disease
International Journal of Biological Sciences · 2024 · 20 (1) · 113-126
DOI: 10.7150/ijbs.87305 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Biological Sciences, 2024. Verfasst von Zhenhua Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 58-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Non-alcoholic fatty liver disease (NAFLD) is a global health burden closely linked to insulin resistance, obesity, and type 2 diabetes. The complex pathophysiology of NAFLD involves multiple cellular pathways and molecular factors. Nuclear receptors (NRs) have emerged as crucial regulators of lipid metabolism and inflammation in NAFLD, offering potential therapeutic targets for NAFLD. Targeting PPARs and FXRs has shown promise in ameliorating NAFLD symptoms and halting disease progression. However, further investigation is needed to address side effects and personalize therapy approaches. This review summarizes the current understanding of the involvement of NRs in the pathogenesis of NAFLD and explores their therapeutic potential. We discuss the role of several NRs in modulating lipid homeostasis in the liver, including peroxisome proliferator-activated receptors (PPARs), liver X receptors (LXRs), farnesoid X receptors (FXRs), REV-ERB, hepatocyte nuclear factor 4α (HNF4α), constitutive androstane receptor (CAR) and pregnane X receptor (PXR).The expanding knowledge of NRs in NAFLD offers new avenues for targeted therapies, necessitating exploration of novel treatment strategies and optimization of existing approaches to combat this increasingly prevalent disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China.
- Clinical Medicine Research Center for Hepatic Surgery of Hubei Province, Wuhan 430030, Hubei Province, China.
- Department and Institute of Infectious Disease, Tongji Hospital, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonostic Infectious Disease, Huazhong University of Science and Tec…
Zitieren
APA
Yang, Z., Danzeng, A., Liu, Q., Zeng, C., Xu, L., Mo, J., Pingcuo, C., Wang, X., Wang, C., Zhang, B., & Zhang, B. (2024). The Role of Nuclear Receptors in the Pathogenesis and Treatment of Non-alcoholic Fatty Liver Disease. International Journal of Biological Sciences, 20(1), 113-126. https://doi.org/10.7150/ijbs.87305
Vancouver
Yang Z, Danzeng A, Liu Q, Zeng C, Xu L, Mo J, et al. The Role of Nuclear Receptors in the Pathogenesis and Treatment of Non-alcoholic Fatty Liver Disease. International Journal of Biological Sciences. 2024;20(1):113-126. doi:10.7150/ijbs.87305
BibTeX
@article{Yang2024,
author = {Yang, Zhenhua and Danzeng, Awang and Liu, Qiumeng and Zeng, Chenglong and Xu, Lei and Mo, Jie and Pingcuo, Ciren and Wang, Xiaojing and Wang, Chao and Zhang, Bixiang and Zhang, Binhao},
title = {The Role of Nuclear Receptors in the Pathogenesis and Treatment of Non-alcoholic Fatty Liver Disease},
journal = {International Journal of Biological Sciences},
year = {2024},
volume = {20},
number = {1},
pages = {113--126},
doi = {10.7150/ijbs.87305}
}
EUVIMED